Home | All trials

[RDF data]
Trial NCT00000449

Resource URI: http://static.linkedct.org/resource/trials/NCT00000449
PropertyValue
linkedct:brief_title Behavior and Naltrexone Treatment for Alcoholics
linkedct:condition <http://static.linkedct.org/resource/condition/744>
linkedct:criteria Inclusion Criteria: - Meets criteria for alcohol dependence. Exclusion Criteria: - Current diagnosis of dependence on other substances except nicotine. - A history of psychosis or current psychotic symptoms. - Current suicidality, homocidality, or psychiatric symptoms that require additional medication. - Current use of disulfiram (Antabuse). - Evidence of significant cerebral, renal, thyroid, or cardiac disease. - History of opioid abuse in the previous year. - History of cirrhosis, hepatocellular disease, or elevated bilirubin. - Females who are pregnant, nursing, or not using a reliable method of birth control.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 65 Years
linkedct:eligibility_minimum_age 18 Years
linkedct:end_date March 2000
linkedct:enrollment 160 (xsd:int)
linkedct:firstreceived_date November 2, 1999
linkedct:id NCT00000449
rdfs:label Trial NCT00000449
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Alcohol Abuse and Alcoholism (NIAAA)
linkedct:location <http://static.linkedct.org/resource/location/148965>
linkedct:nct_id NCT00000449
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Coping, Exposure, and Naltrexone Treatment With Alcoholics
linkedct:org_study_id NIAAAMON7850
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000449>
linkedct:phase Phase 4
linkedct:source National Institute on Alcohol Abuse and Alcoholism (NIAAA)
linkedct:study_design Treatment, Randomized, Factorial Assignment, Efficacy Study
linkedct:study_type Interventional
linkedct:summary The study's purpose is to improve alcoholism treatment by investigating the combined effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment - CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of CSTCET or a control treatment as inpatients followed by 12 consecutive weeks of receiving either naltrexone or placebo as outpatients. Followups at 24, 48, and 72 weeks after treatment is completed.
rdf:type linkedct:trials
linkedct:verification_date August 2002